Abstract
The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have